Diabetes treatment is constantly evolving, with new therapeutic options developing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the actions https://saulzyln095766.blogdon.net/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment-55052522